# FIRDAPSE
> **NDA208078** · New Drug Application · Sponsor: CATALYST PHARMS · Approved 2018-11-28
## Drug
- **FDA Application Number:** NDA208078
- **Application type:** New Drug Application
- **Brand name:** FIRDAPSE
- **Generic name:** AMIFAMPRIDINE PHOSPHATE
- **Active ingredients:** AMIFAMPRIDINE PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CATALYST PHARMS
- **Manufacturer:** Catalyst Pharmaceuticals, Inc.
- **First approval:** 2018-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208078)
---
*MORVS · CC0 1.0*